Proscia vs athenahealth
Side-by-side comparison of AI visibility scores, market position, and capabilities
Proscia provides a digital pathology platform (Concentriq) that digitizes glass slide workflows and applies AI to accelerate and improve cancer diagnosis; raised $37M including a $25M Series B; FDA-cleared AI applications;
About
Proscia is a Philadelphia-based health technology company founded in 2014 that has developed a digital and computational pathology platform — called Concentriq — designed to transform how pathologists diagnose cancer and how pharmaceutical companies conduct drug discovery research. Pathology has historically been one of the last medical specialties to transition from analog to digital workflows: the standard of care still involves pathologists examining glass microscope slides by hand under optical microscopes. Proscia's Concentriq platform digitizes these glass slides using whole-slide imaging scanners, stores the resulting high-resolution digital images in a cloud-based repository, and provides pathologists with an AI-augmented viewer that can highlight diagnostic features, flag regions of interest, and assist with quantitative analysis that would be time-consuming or impossible to perform manually.
$1.7B annual revenue; 160K+ providers, 117M patients; 18.15% EHR market share; 6,713+ companies using 2025; acquired by Bain Capital & Hellman & Friedman Nov 2021 at $17B; AI interoperability 2025
About
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on the principle that healthcare administration should be managed as a service — with athenahealth absorbing the complexity of payer rule updates, regulatory compliance, and billing workflows so that physicians and clinical staff can focus entirely on patient care. Its cloud-native architecture, deployed before most EHR competitors moved to the cloud, remains a core technical differentiator.\n\nathenahealth's platform — athenaOne — integrates EHR, revenue cycle management, patient engagement, and care coordination in a single system used by over 160,000 providers across 117 million patient records. The company serves ambulatory practices ranging from solo physicians to large health systems and medical groups. Its continuously updated rules engine processes millions of payer transactions daily, enabling higher clean claim rates and faster reimbursement compared to on-premise EHR alternatives. athenahealth holds an 18.15% share of the US ambulatory EHR market.\n\nathenahealth is currently owned by a private equity consortium of Bain Capital and Hellman & Friedman, which acquired the company in 2019 for $5.7 billion. Annual revenue stands at approximately $1.7 billion. The company competes with Epic, eClinicalWorks, and Oracle Health in the ambulatory EHR market. Its managed-service model, shared payer network data, and cloud-native infrastructure continue to make it a compelling choice for ambulatory providers who prioritize revenue cycle performance and reduced administrative burden.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.